key: cord-0761207-9uuyuqt9
authors: Celli, Bartolome; Fabbri, Leonardo M.
title: Urgent need of a management plan for survivors of COVID-19
date: 2020-03-26
journal: Eur Respir J
DOI: 10.1183/13993003.00764-2020
sha: 6a35a7fceff4d0f15abbe4aa33411c711cac6c5b
doc_id: 761207
cord_uid: 9uuyuqt9

Acute exacerbations of COPD (AECOPD) or “COPD crises” [1], are crucial events in the natural course of COPD. Although they can occur at any severity stage, their impact increases as patients develop more severe airflow limitation.

Acute exacerbations of COPD (AECOPD) or "COPD crises" [1] , are crucial events in the natural course of COPD. Although they can occur at any severity stage, their impact increases as patients develop more severe airflow limitation.

Several studies have demonstrated that the occurrence of COPD exacerbations increases the risk of myocardial infarction and stroke [2] , all cause [3, 4] and cardiovascular mortality [5] , in the post exacerbation period, particularly in AECOPD with associated pneumonia [6] . This was best demonstrated by Kunisaki et al in a pre-specified analysis of the data from the SUMMIT trial of over 16 thousand patients with moderate COPD and heightened cardiovascular risk [7] . The authors found that the hazard ratio (HR) for cardiovascular events was increased, particularly in the first 30 days after the exacerbations (HR, 3.8; 95% CI, 2.7-5.5). The risk increased more than twofold if the exacerbations lead to a hospitalization; where the HR reached 9.9 (95% CI, 6.6-14.9 ). This study was important because all deaths were analyzed by a clinical end-point committee. There was an unusually high number of cardiovascular events occurring after the exacerbations suggesting some vascular dysfunction leading to myocardial infarction, stroke and pulmonary embolism.

This scenario appears to be similar to that reported to occur following hospitalized pneumonias, particularly in the elderly [8] [9] [10] .

The current pandemia of COVID-19 affects primarily adults and particularly those affected by one or more chronic diseases [11] . Because most of the severe COVID-19 are due to pneumonia associated with respiratory failure [11, 12] , it is likely that similarly to patients with exacerbations of COPD and/or community acquired pneumonia, the survivors of COVID will be at high risk of cardiovascular events and mortality following the acute phase of the disease. We would like to call attention to this vulnerable period, and recommend that patients be closely followed with a management plan that pays special attention to the prompt recognition of cardiovascular complications, especially in the 30 days following the resolution of the acute phase of the event. It would be a pity that those survivors of COVID-19 pneumonia, would then succumb from a relatively preventable consequence.

Exacerbations of chronic obstructive pulmonary disease: time to rename

Increased risk of myocardial infarction and stroke following exacerbation of COPD

Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort

Risk of death and readmission of hospitaladmitted COPD exacerbations: European COPD Audit. The European respiratory journal

Mortality of cardiovascular events in COPD patients with preceding hospitalized acute exacerbation

Early readmission and mortality in acute exacerbation of chronic obstructive pulmonary disease with community-acquired pneumonia

Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial

Acute respiratory distress syndrome in mechanically ventilated patients with community-acquired pneumonia

Community-Acquired Pneumonia Requiring Hospitalization among U

Incremental risk of long-term mortality with increased burden of comorbidity in hospitalized patients with pneumonia

Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease